These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 24383515)
1. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening. Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515 [TBL] [Abstract][Full Text] [Related]
2. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672 [TBL] [Abstract][Full Text] [Related]
3. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism. Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349 [TBL] [Abstract][Full Text] [Related]
10. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning. Ni J; Ge J; Zhang M; Hussain K; Guan Y; Cheng R; Xi L; Zheng Z; Ren S; Luo F Eur J Pediatr; 2019 Aug; 178(8):1161-1169. PubMed ID: 31218401 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism. Yorifuji T; Kawakita R; Hosokawa Y; Fujimaru R; Matsubara K; Aizu K; Suzuki S; Nagasaka H; Nishibori H; Masue M Clin Endocrinol (Oxf); 2013 Jun; 78(6):891-7. PubMed ID: 23067144 [TBL] [Abstract][Full Text] [Related]
12. Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11. Hewat TI; Yau D; Jerome JCS; Laver TW; Houghton JAL; Shields BM; Flanagan SE; Patel KA Eur J Endocrinol; 2021 Oct; 185(6):813-818. PubMed ID: 34633981 [TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation. Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534 [TBL] [Abstract][Full Text] [Related]
14. The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children with Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia. Dastamani A; Güemes M; Pitfield C; Morgan K; Rajab M; Rottenburger C; Bomanji J; De Coppi P; Dattani M; Shah P Horm Res Paediatr; 2019; 91(1):56-61. PubMed ID: 30114684 [TBL] [Abstract][Full Text] [Related]
15. KATP channel mutations in congenital hyperinsulinism. Saint-Martin C; Arnoux JB; de Lonlay P; Bellanné-Chantelot C Semin Pediatr Surg; 2011 Feb; 20(1):18-22. PubMed ID: 21185999 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of ABCC8, KCNJ11, GLUD1, HNF4A and GCK genes in 30 Chinese patients with congenital hyperinsulinism. Sang Y; Xu Z; Liu M; Yan J; Wu Y; Zhu C; Ni G Endocr J; 2014; 61(9):901-10. PubMed ID: 25008049 [TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience. Gundogdu S; Ciftci M; Atay E; Ayaz A; Ceran O; Atay Z J Pediatr Endocrinol Metab; 2023 Jan; 36(1):53-57. PubMed ID: 36409572 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations. Demirbilek H; Arya VB; Ozbek MN; Akinci A; Dogan M; Demirel F; Houghton J; Kaba S; Guzel F; Baran RT; Unal S; Tekkes S; Flanagan SE; Ellard S; Hussain K Eur J Endocrinol; 2014 Jun; 170(6):885-92. PubMed ID: 24686051 [TBL] [Abstract][Full Text] [Related]
19. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia. Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418 [TBL] [Abstract][Full Text] [Related]
20. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China. Xu A; Cheng J; Sheng H; Wen Z; Lin Y; Zhou Z; Zeng C; Shao Y; Li C; Liu L; Li X J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):400-409. PubMed ID: 31208162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]